Product Images Protonix Delayed-release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Protonix Delayed-release NDC 0008-0844 by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - protonix 01

Chemical Structure - protonix 01

Logo - protonix 02

Logo - protonix 02

This is a label of a pharmaceutical product distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. headquartered in Philadelphia, PA 19101.*

protonix 02a

protonix 02a

This is a medication from Pfizer that is distributed through its subsidiary Wyeth Pharmaceuticals LLC based in Philadelphia, PA 19101.*

Logo - protonix 03

Logo - protonix 03

This is a product label or package distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The company is located in Philadelphia, PA 19101.*

Principal Display Panel - 20 mg Tablet Bottle Label - protonix 04

Principal Display Panel - 20 mg Tablet Bottle Label - protonix 04

This seems to be a description of a medication named "Pantoprazole" in the form of delayed-release tablets. Each tablet contains 20mg of Pantoprazole or equivalent to 22.56 mg of Pantoprazole sodium. It is recommended to swallow the tablet as a whole and not to split, chew or crush it. The usual dosage is not available, but it is advised to store the medication between 20°-25°C (68°-77°F), and excursions are permitted to 15°-30°C (50°-86°F).*

Principal Display Panel - 40 mg Tablet Bottle Label - protonix 05

Principal Display Panel - 40 mg Tablet Bottle Label - protonix 05

This appears to be a medication guide for Pantoprazole sodium, delayed-release tablets with a 40mg dosage of Pantoprazole. The guide includes instructions to swallow the tablet whole and not split, chew, or crush it. It also includes information on storage conditions. The rest of the text is not legible due to errors.*

Principal Display Panel - 40 mg Granule Packet - protonix 06

Principal Display Panel - 40 mg Granule Packet - protonix 06

This is a description of a medication, called Pantoprazole sodium, in delayed-release oral suspension form. Each packet contains 40mg of Pantoprazole (equivalent to 45.1 mg of Pantoprazole sodium) and should only be taken in suspension with apple juice or applesauce. The medicinal product is by Protonix and only available as a prescription. The remaining text is not available due to errors.*

Principal Display Panel - 40 mg Granule Packet Carton - protonix 07

Principal Display Panel - 40 mg Granule Packet Carton - protonix 07

Protonix is a medication available in the form of delayed-release Oral Suspension. The medication comes in packets and each packet contains Pantoprazole Sodium, which is equivalent to 45.1 mg of pantoprazole at 40 mg concentration. The medicine should always be dispensed with a medication guide. The medication can be administered with applesauce or apple juice only after stirring. Protonix should not be crushed or chewed and should be taken 30 minutes before a meal. The complete direction of use and dosing instructions can be obtained from the package insert. Keep the medication out of reach of children, and store it at 68° to 77°F, with excursions permitted to 59° to 86°F. The manufacturer of the medicine is Wyeth Pharmaceuticals sold under license from Takeda GmbH, Germany.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.